Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2022 Sterile Drug Market Report
2022 API Market Report
2022 OSD Market Report
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Biomanufacturing
53 Articles Available
1
3
Can't find what you're looking for? Try our
advanced search
.
Biomanufacturing
On the Journey to a New Industry Standard for E. coli-based Protein Production
PAO-03-23-CL-03
Biomanufacturing
An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market
PAO-01-23-CL-04
Anti-Idiotype Antibodies
Rapid Supply of Anti-Idiotype Antibodies Facilitates Preclinical and Clinical Antibody-Based Drug Development
PAO-01-23-CL-01
Recombinant Proteins
The Expanding Role for Recombinant Proteins in Research
PAO-11-22-PATV-01
Biomanufacturing
Scorpion Biological Services Becomes Scorpius BioManufacturing to Reflect Expansion
PR-M12-22-02
CDMO
Goodwin Biotechnology Inc. is Now GBI, as Part of their Rebranding Initiative on Their 30-Year Anniversary!
PR-M12-22-02
Biomanufacturing
New Name, Same Expertise: Goodwin Biotechnology is Becoming GBI!
PAO-11-022-CL-11
Cell Line Development Technology
Wheeler Bio Licenses ATUM’s Proprietary Leap-In Transposase® Technology in Support of its Disruptive CDMO Service Offering
PR-M11-22-09
New Facility
Scorpion Biological Services Celebrates Grand Opening of its San Antonio Facility
PR-M10-22-08
Biomanufacturing Facility
OmniaBio, CCRM and Stakeholders Celebrate Commencement of Construction of Hamilton Biomanufacturing Facility
PR-M10-22-05
Series A Funding
Wheeler Bio Announces Initial Closing of Series A Round Supporting New Biologics Drug Substance GMP Expansion In Oklahoma
PR-M10-22-02
Speed to Clinic
Leveraging Experience to Reduce Timelines for IND-Enabling Activities
PAO-09-022-CL-04
Pharma 4.0
Applying an Advanced Pharma 4.0 Perspective to Design the Facility of the Future
PAO-06-022-CL-11
Multispecific Antibodies
Optimized Multispecific Antibody Design, Development, and Manufacturing
PAO-08-022-CL-04
Patented Production Strains
Adding Value with Patent Protection for Novel, Tailor-Made Bacterial Production Strains
PAO-08-022-CL-03
Biomanufacturing
Optimizing Fed-Batch Processes with Chemically Defined Media and Feeds
PAO-07-022-CL-02
Column: M&A
Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.
PAO-06-022--NI-12
Financing
Enzymaster Completes Round-C Financing to Accelerate Innovation, Increase Capabilities, and Expand Capacity
PR-M05-22-07
Biomanufacturing
A Next-Generation Baker’s Yeast Biofoundry Presents Transformative Potential for Biomanufacturing
PAO-04-022-CL-10
Biomanufacturing
The Smart Approach to Preclinical Development for Bacterially Expressed Biologics
PAO-04-022-CL-13
New Biodefense Facility
Scorpion Biological Services Announces New Kansas Commercial Biomanufacturing Facility
PR-M04-22-12
New Biodefense Facility
Heat Biologics’ Scorpion Subsidiary Announces Planned Development of New Kansas Commercial/Biodefense Biomanufacturing Facility
PR-M04-22-10
Recombinant Antibodies
Taking a Customer-Focused Approach to Custom Antibody Development and Manufacturing
PAO-04-022-CL-01
Biomanufacturing
Unique Vector Expression Technologies for Boosting Protein Production in E. coli
PAO-02-022-CL-16
1
3
»
